Current strategies for oral delivery of BCS IV drug nanocrystals: challenges, solutions and future trends

References

• Kaur G, Arora M, Ravi KM. Oral drug delivery technologies-A decade of developments. J Pharmacol Exp Ther. 2019;370(3):529–543.
   PubMed Web of Science ®Google Scholar
• Ghadi R, Dand N. BCS class IV drugs: highly notorious candidates for formulation development. J Control Release. 2017;248:71–95.
   PubMed Web of Science ®Google Scholar
• Raza A, Ngieng S, Sime F, et al. Oral meropenem for superbugs: challenges and opportunities. Drug Discov Today. 2020;13(20):s1359–6446.
   Google Scholar
• Amidon GL, Lennernas H, Shah VP, et al. A theoretical basis for a biopharmaceutic drug classification: the correlation of in vitro drug product dissolution and in vivo bioavailability. Pharm Res. 1995;12(3):413–420.
   PubMed Web of Science ®Google Scholar
• Ambrogi V, Perioli L, Pagano C, et al. Use of SBA-15 for furosemide oral delivery enhancement. Eur J Pharm Sci. 2012;46(1–2):43–48.
   PubMed Web of Science ®Google Scholar
• Li Y, Sun S, Chang Q, et al. A strategy for the improvement of the bioavailability and antiosteoporosis activity of BCS iv flavonoid glycosides through the formulation of their lipophilic aglycone into nanocrystals. Mol Pharm. 2013;10(7):2534–2542.
   PubMedGoogle Scholar
• Cirri M, Maestrini L, Maestrelli F, et al. Design, characterization and in vivo evaluation of nanostructured lipid carriers (NLC) as a new drug delivery system for hydrochlorothiazide oral administration in pediatric therapy. Drug Deliv. 2018;25(1):1910–1921.
   PubMed Web of Science ®Google Scholar
• Shah JC, Chen JR, Chow D. Preformulation study of etoposide: identification of physicochemical characteristics responsible for the low and erratic oral bioavailability of etoposide. Pharm Res. 1989;6(5):408.
   PubMed Web of Science ®Google Scholar
• D’Errico S, Baldari B, Arcangeli M, et al. Mast cells activation and high blood tryptase levels due to paclitaxel administration. Is Cremophor EL the culprit? Medicine (Baltimore). 2020;99(43):e22814. A case report.
   PubMed Web of Science ®Google Scholar
• Pathak K, Raghuvanshi S. Oral bioavailability: issues and solutions via nanoformulations. Clin Pharmacokinet. 2015;54(4):325–357.
   PubMed Web of Science ®Google Scholar
• Daeihamed M, Haeri A, Ostad S, et al. Doxorubicin-loaded liposomes: enhancing the oral bioavailability by modulation of physicochemical characteristics. Nanomedicine. 2017;12(10):1187–1202.
   PubMed Web of Science ®Google Scholar
• He H, Lu Y, Qi J, et al. Adapting liposomes for oral drug delivery. Acta Pharm Sin B. 2019;9(1):36–48.
   PubMed Web of Science ®Google Scholar
• Dian L, Hu Y, Lin J, et al. Fabrication of paclitaxel hybrid nanomicelles to treat resistant breast cancer via oral administration. Int J Nanomedicine. 2018;13:719–731.
   PubMed Web of Science ®Google Scholar
• Simões S, Figueiras A, Veiga F, et al. Polymeric micelles for oral drug administration enabling locoregional and systemic treatments. Expert Opin Drug Deliv. 2015;12(2):297–318.
   PubMed Web of Science ®Google Scholar
• Khalid N, Sarfraz M, Arafat M, et al. Nano-sized droplets of self-emulsifying system for enhancing oral bioavailability of chemotherapeutic agent VP-16 in rats: a nano lipid carrier for BCS class IV drugs. J Pharm Pharm Sci. 2018;21(1):398–408.
   PubMedGoogle Scholar
• Pandey M, Choudhury H, Yeun O, et al. Perspectives of nanoemulsion strategies in the improvement of oral, parenteral and transdermal chemotherapy. Curr Pharm Biotechnol. 2018;19(4):276–292.
   PubMed Web of Science ®Google Scholar
• Zhu Y, Liang X, Lu C, et al. Nanostructured lipid carriers as oral delivery systems for improving oral bioavailability of Nintedanib by promoting intestinal absorption. Int J Pharm. 2020;586:119569.
   PubMedGoogle Scholar
• Gaba B, Fazil M, Ali A, et al. Nanostructured lipid (NLCs) carriers as a bioavailability enhancement tool for oral administration. Drug Deliv. 2015;22(6):691–700.
   PubMed Web of Science ®Google Scholar
• Abeer M, Meka A, Pujara N, et al. Rationally designed dendritic silica nanoparticles for oral delivery of exenatide. Pharmaceutics. 2019;11(8):418.
   Web of Science ®Google Scholar
• Abbaraju P, Meka A, Jambhrunkar S, et al. Floating tablets from mesoporous silica nanoparticles. J Mater Chem B. 2014;2(47):8298–8302.
   PubMed Web of Science ®Google Scholar
• Juère E, Del Favero G, Masse F, et al. Gastro-protective protein-silica nanoparticles formulation for oral drug delivery: in vitro release, cytotoxicity and mitochondrial activity. Eur J Pharm Biopharm. 2020;151:171–180.
   PubMed Web of Science ®Google Scholar
• Abeer M, Rewatkar P, Qu Z, et al. Silica nanoparticles: a promising platform for enhanced oral delivery of macromolecules. J Control Release. 2020;326:544–555.
   PubMed Web of Science ®Google Scholar
• Ren T, Wang Q, Xu Y, et al. Enhanced oral absorption and anticancer efficacy of cabazitaxel by overcoming intestinal mucus and epithelium barriers using surface polyethylene oxide (PEO) decorated positively charged polymer-lipid hybrid nanoparticles. J Control Release. 2018;269:423–438.
   PubMed Web of Science ®Google Scholar
• Beloqui A, Des Rieux A, Préat V. Mechanisms of transport of polymeric and lipidic nanoparticles across the intestinal barrier. Adv Drug Deliv Rev. 2016;106(Pt B):242–255.
   PubMedGoogle Scholar
• Qin SY, Zhang AQ, Cheng SX, et al. Drug self-delivery systems for cancer therapy. Biomaterials. 2016;112:234–247.
   PubMed Web of Science ®Google Scholar
• Cai K, He X, Song Z, et al. Dimeric drug polymeric nanoparticles with exceptionally high drug loading and quantitative loading efficiency. J Am Chem Soc. 2015;137(10):3458–3461.
   PubMed Web of Science ®Google Scholar
• Gao L, Liu G, Ma J, et al. Drug nanocrystals: in vivo performances. J Control Release. 2012;160(3):418–430.
   PubMed Web of Science ®Google Scholar
• Pawar VK, Singh Y, Meher JG, et al. Engineered nanocrystal technology: in-vivo fate, targeting and applications in drug delivery. J Control Release. 2014;183(1):51–66.
   PubMedGoogle Scholar
• Pardhi V, Verma T, Flora S, et al. Nanocrystals: an overview of fabrication, characterization and therapeutic applications in drug delivery. Curr Pharm Des. 2018;24(43):5129–5146.
   PubMed Web of Science ®Google Scholar
• Kojo Y, Kobayashi K, Matsunaga S, et al. Avoidance of food effect on oral absorption profile of itraconazole by self-micellizing solid dispersion approach. Drug Metab Pharmacokinet. 2017;32(5):273–276.
   PubMed Web of Science ®Google Scholar
• Meola T, Dening T, Prestidge C. Nanocrystal-silica-lipid hybrid particles for the improved oral delivery of ziprasidone in vitro. Eur J Pharm Biopharm. 2018;129:145–153.
   PubMed Web of Science ®Google Scholar
• Lei G, Liu G, Ma J, et al. Application of drug nanocrystal technologies on oral drug delivery of poorly soluble drugs. Pharm Res. 2013;30(2):307–324.
   PubMed Web of Science ®Google Scholar
• Junyaprasert VB, Morakul B. Nanocrystals for enhancement of oral bioavailability of poorly water-soluble drugs. Asian J Pharm. 2015;10(1):13–23.
   Web of Science ®Google Scholar
• Lu Y, Chen Y, Gemeinhart RA, et al. Developing nanocrystals for cancer treatment. Nanomedicine. 2015;10(16):2537–2552.
   PubMed Web of Science ®Google Scholar
• Havel HA. Where are the nanodrugs? An industry perspective on development of drug products containing nanomaterials. Aaps J. 2016;18(6):1–3.
   PubMed Web of Science ®Google Scholar
• Kwon H, Heo E, Kim Y, et al. Development and evaluation of poorly water-soluble celecoxib as solid dispersions containing nonionic surfactants using fluidized-bed granulation. Pharmaceutics. 2019;11(3):136.
   Web of Science ®Google Scholar
• Liu J, Tu L, Cheng M, et al. Mechanisms for oral absorption enhancement of drugs by nanocrystals. J Drug Deliv Sci Tec. 2020;56:101607.
   Web of Science ®Google Scholar
• Mohammad IS, Hu H, Yin L, et al. Drug nanocrystals: fabrication methods and promising therapeutic applications. Int J Pharm. 2019;562:187–202.
   PubMedGoogle Scholar
• Jinno J, Kamada N, Miyake M, et al. Effect of particle size reduction on dissolution and oral absorption of a poorly water-soluble drug, cilostazol, in beagle dogs. J Control Release. 2006;111(1):56–64.
   PubMed Web of Science ®Google Scholar
• Dengning X, Fude C, Hongze P, et al. Effect of crystal size on the in vitro dissolution and oral absorption of nitrendipine in rats. Pharm Res. 2010;27(9):1965–1976.
   PubMed Web of Science ®Google Scholar
• Zhang J, Lv H, Jiang K, et al. Enhanced bioavailability after oral and pulmonary administration of baicalein nanocrystal. Int J Pharm. 2011;420(1):180–188.
   PubMed Web of Science ®Google Scholar
• Mou D, Chen H, Wan J, et al. Potent dried drug nanosuspensions for oral bioavailability enhancement of poorly soluble drugs with pH-dependent solubility. Int J Pharm. 2011;413(1–2):237–244.
   PubMedGoogle Scholar
• Hao L, Wang X, Zhang D, et al. Studies on the preparation, characterization and pharmacokinetics of Amoitone B nanocrystals. Int J Pharm. 2012;433(1–2):157–164.
   PubMedGoogle Scholar
• Jiang T, Han N, Zhao B, et al. Enhanced dissolution rate and oral bioavailability of simvastatin nanocrystal prepared by sonoprecipitation. Drug Dev Ind Pharm. 2012;38(10):1230–1239.
   PubMed Web of Science ®Google Scholar
• Huang Y, Luo X, You X, et al. The preparation and evaluation of water-soluble sklb610 nanosuspensions with improved bioavailability. AAPS PharmSciTech. 2013;14(3):1236–1243.
   PubMed Web of Science ®Google Scholar
• Fu Q, Sun J, Zhang D, et al. Nimodipine nanocrystals for oral bioavailability improvement: preparation, characterization and pharmacokinetic studies. Colloids Surf B Biointerfaces. 2013;109:161–166.
   PubMed Web of Science ®Google Scholar
• Srivalli KMR, Mishra B. Preparation and pharmacodynamic assessment of ezetimibe nanocrystals: effect of P-gp inhibitory stabilizer on particle size and oral absorption. Colloids Surf B Biointerfaces. 2015;135:756–764.
   PubMed Web of Science ®Google Scholar
• Guo M, Fu Q, Wu C, et al. Rod shaped nanocrystals exhibit superior in vitro dissolution and in vivo bioavailability over spherical like nanocrystals: a case study of lovastatin. Colloids Surf B Biointerfaces. 2015;128:410–418.
   PubMed Web of Science ®Google Scholar
• Du P, Jiang Q, Yang R, et al. Nanonization of andrographolide by a wet milling method: the effects of vitamin E TPGS and oral bioavailability enhancement. RSC Adv. 2016;10(1039):C6RA16002F.
   Google Scholar
• Lei Y, Kong Y, Sui H, et al. Enhanced oral bioavailability of glycyrrhetinic acid via nanocrystal formulation. Drug Deliv Transl Res. 2016;6(5):1–7.
   PubMed Web of Science ®Google Scholar
• Chen T, Li Y, Wu W, et al. Enhanced dissolution, oral bioavailability and brain delivery by formulation schisantherin a into nanocrystals. Nanomedicine. 2016;2(12):503.
   Google Scholar
• Fu Q, Ma M, Li M, et al. Improvement of oral bioavailability for nisoldipine using nanocrystals. Powder Technol. 2017;305:757–763.
   Web of Science ®Google Scholar
• He J, Han Y, Xu G, et al. Preparation and evaluation of celecoxib nanosuspensions for bioavailability enhancement. Rsc Adv. 2017;7(22):13053–13064.
   Web of Science ®Google Scholar
• Chang D, Ma Y, Cao G, et al. Improved oral bioavailability for lutein by nanocrystal technology: formulation development, in vitro and in vivo evaluation. Artif Cells Nanomed Biotechnol. 2018;46(5):1018–1024.
   PubMed Web of Science ®Google Scholar
• Wu Y, Loper A, Landis E, et al. The role of biopharmaceutics in the development of a clinical nanoparticle formulation of MK-0869: a Beagle dog model predicts improved bioavailability and diminished food effect on absorption in human. Int J Pharm. 2004;285(1–2):135–146.
   PubMed Web of Science ®Google Scholar
• Patel K, Patil A, Mehta M, et al. Oral delivery of paclitaxel nanocrystal (PNC) with a dual Pgp-CYP3A4 inhibitor: preparation, characterization and antitumor activity. Int J Pharm. 2014;472(1–2):214–223.
   PubMedGoogle Scholar
• Guo Y, Wang Y, Xu L. Enhanced bioavailability of rebamipide nanocrystal tablets: formulation and in vitro/in vivo evaluation. Asian J Pharm. 2015;10(3):223–229.
   Google Scholar
• He Y, Xia D-N, Li Q-X, et al. Enhancement of cellular uptake, transport and oral absorption of protease inhibitor saquinavir by nanocrystal formulation. Acta Pharmacol Sin. 2015;36(9):1151–1160.
   PubMed Web of Science ®Google Scholar
• Sharma S, Verma A, Teja B, et al. Development of stabilized Paclitaxel nanocrystals: in-vitro and in-vivo efficacy studies. Eur J Pharm Sci. 2015;69:51–60.
   PubMed Web of Science ®Google Scholar
• Sharma S, Verma A, Pandey G, et al. Investigating the role of Pluronic-g-Cationic polyelectrolyte as functional stabilizer for nanocrystals: impact on Paclitaxel oral bioavailability and tumor growth. Acta Biomater. 2015;26(3):169–183.
   PubMedGoogle Scholar
• Song Y, Han J, Feng R, et al. The 12-3-12 cationic Gemini surfactant as a novel gastrointestinal bioadhesive material for improving the oral bioavailability of coenzyme Q10 naked nanocrystals. Drug Dev Ind Pharm. 2016;42(12):2044–2054.
   PubMed Web of Science ®Google Scholar
• Wei X, Wei S, L K G, et al. Dual-functional Brij-S20-modified nanocrystal formulation enhances the intestinal transport and oral bioavailability of berberine. Int J Nanomedicine. 2018;13:3781–3793.
   PubMed Web of Science ®Google Scholar
• Xu X, Chen G, Li Y, et al. Enhanced dissolution and oral bioavailability of cinacalcet hydrochloride nanocrystals with no food effect. Nanotechnology. 2019;30(5):055102.
   PubMed Web of Science ®Google Scholar
• Wang Y, Wang S, Xu Y, et al. <p>Etoposide Amorphous Nanopowder For Improved Oral Bioavailability: Formulation Development, Optimization, In Vitro And In Vivo evaluation. Int J Nanomedicine. 2020;15:7601–7613.
   PubMed Web of Science ®Google Scholar
• Yancai W, Ying Z, Ling Z, et al. Stability of nanosuspensions in drug delivery. J Control Release. 2016;172(3):1126–1141.
   Google Scholar
• Yang H, Kim H, Jung S, et al. Pharmaceutical strategies for stabilizing drug nanocrystals. Curr Pharm Des. 2018;24(21):2362–2374.
   PubMed Web of Science ®Google Scholar
• Deng J, Huang L, Liu F. Understanding the structure and stability of paclitaxel nanocrystals. Int J Pharm. 2010;390(2):242–249.
   PubMedGoogle Scholar
• Kathrin F, Schulz JD, Gauthier MA, et al., PEG nanocages as non-sheddable stabilizers for drug nanocrystals. Acs Nano. 6(2): 1667–1676. 2012. .
   PubMed Web of Science ®Google Scholar
• Wang N, Zhang Y, Liu H, et al. Toxicity reduction and efficacy promotion of doxorubicin in the treatment of breast tumors assisted by enhanced oral absorption of curcumin-loaded lipid-polyester mixed nanoparticles. Mol Pharm. 2020;17(12):4533–4547.
   PubMedGoogle Scholar
• Miao L, Liang Y, Pan W, et al. Effect of supersaturation on the oral bioavailability of paclitaxel/polymer amorphous solid dispersion. Drug Deliv Transl Res. 2019;9(1):344–356.
   PubMed Web of Science ®Google Scholar
• Xia D, Quan P, Piao H, et al. Preparation of stable nitrendipine nanosuspensions using the precipitation–ultrasonication method for enhancement of dissolution and oral bioavailability. Eur J Pharm Sci. 2010;40(4):325–334.
   PubMed Web of Science ®Google Scholar
• Xia D, He Y, Li Q, et al. Transport mechanism of lipid covered saquinavir pure drug nanoparticles in intestinal epithelium. J Control Release. 2018;269:159–170.
   PubMed Web of Science ®Google Scholar
• Murgia X, Loretz B, Hartwig O, et al. The role of mucus on drug transport and its potential to affect therapeutic outcomes. Adv Drug Deliv Rev. 2018;124:82–97.
   PubMed Web of Science ®Google Scholar
• Allen A, Cunliffe WJ, Pearson JP, et al. The adherent gastric mucus gel barrier in man and changes in peptic ulceration. Journal of Internal Medicine. 1990;228(S732):83–90.
   PubMedGoogle Scholar
• Bansil R, Turner BS. The biology of mucus: composition, synthesis and organization. Adv Drug Deliv Rev. 2017;124:3–15.
   PubMed Web of Science ®Google Scholar
• Pearson JP, Chater PI, Wilcox MD. The properties of the mucus barrier, a unique gel – how can nanoparticles cross it? Ther Deliv. 2016;7(4):229–244.
   PubMed Web of Science ®Google Scholar
• Boegh M, Nielsen H. Mucus as a barrier to drug delivery – understanding and mimicking the barrier properties. Basic Clin Pharmacol Toxicol. 2015;116(3):179–186.
   PubMed Web of Science ®Google Scholar
• Lai SK, Wang YY, Hanes J. Mucus-penetrating nanoparticles for drug and gene delivery to mucosal tissues. Adv Drug Deliv Rev. 2009;61(2):158–171.
   PubMed Web of Science ®Google Scholar
• Weiss TH, Mills AL, Hornberger GM, et al. Effect of bacterial cell shape on transport of bacteria in porous media. Environ Sci Technol. 1995;29(7):1737–1740.
   PubMed Web of Science ®Google Scholar
• Yu M, Wang J, Yang Y, et al., Rotation-facilitated rapid transport of nanorods in mucosal tissues. Nano Lett. 16(11): 7176–7182. 2016.
   PubMed Web of Science ®Google Scholar
• Geng Y, Dalhaimer P, Cai S, et al. Shape effects of filaments versus spherical particles in flow and drug delivery. Nat Nanotechnol. 2007;2(4):249–255.
   PubMed Web of Science ®Google Scholar
• Guo M, Wei M, Li W, et al. Impacts of particle shapes on the oral delivery of drug nanocrystals: mucus permeation, transepithelial transport and bioavailability. J Control Release. 2019;307:64–75.
   PubMed Web of Science ®Google Scholar
• Roy B, Mondal A, Bera S, et al. Using Brownian motion to measure shape asymmetry in mesoscopic matter using optical tweezers. Soft Matter. 2016;12(23):5077–5080.
   PubMed Web of Science ®Google Scholar
• Jurney P, Agarwal R, Singh V, et al. Unique size and shape-dependent uptake behaviors of non-spherical nanoparticles by endothelial cells due to a shearing flow. J Control Release. 2017;245:170–176.
   PubMed Web of Science ®Google Scholar
• Soisuwan S, Teeranachaideekul V, Wongrakpanich A, et al. Impact of uncharged and charged stabilizers on in vitro drug performances of clarithromycin nanocrystals. Eur J Pharm Biopharm. 2019;137:68–76.
   PubMed Web of Science ®Google Scholar
• Zhang X, Cheng H, Dong W, et al. Design and intestinal mucus penetration mechanism of core-shell nanocomplex. J Control Release. 2018;272:29–38.
   PubMed Web of Science ®Google Scholar
• Abdulkarim M, Agulló N, Cattoz B, et al. Nanoparticle diffusion within intestinal mucus: three-dimensional response analysis dissecting the impact of particle surface charge, size and heterogeneity across polyelectrolyte, pegylated and viral particles. Eur J Pharm Biopharm. 2015;97:230–238.
   PubMed Web of Science ®Google Scholar
• Kim S, Seo K, Kim J, et al. The M responses in Mucosal VaccinationCell-Targeting Ligand Promotes Antigen Delivery and Induces Antigen-Specific Immune . J Immunol. 2010;185(10):5787–5795.
   PubMed Web of Science ®Google Scholar
• Islam M, Firdous J, Badruddoza A, et al. M cell targeting engineered biomaterials for effective vaccination. Biomaterials. 2019;192:75–94.
   PubMed Web of Science ®Google Scholar
• Fu Q, Sun J, Ai X, et al. Nimodipine nanocrystals for oral bioavailability improvement: role of mesenteric lymph transport in the oral absorption. Int J Pharm. 2013;448(1):290–297.
   PubMedGoogle Scholar
• Shen C, Yang Y, Shen B, et al. Self-discriminating fluorescent hybrid nanocrystals: efficient and accurate tracking of translocation via oral delivery. Nanoscale. 2018;10(1):436–450.
   Web of Science ®Google Scholar
• Singh B, Maharjan S, Jiang T, et al. Combinatorial approach of antigen delivery using m cell-homing peptide and mucoadhesive vehicle to enhance the efficacy of oral vaccine. Mol Pharm. 2015;12(11):3816–3828.
   PubMed Web of Science ®Google Scholar
• Sass W, Dreyer H-P SJ. Rapid insorption of small particles in the gut. Am J Gastroenterol. 1990;85(3):255–260.
   PubMed Web of Science ®Google Scholar
• Neill MO, Guo J, Byrne C, et al. Mechanistic studies on the uptake and intracellular trafficking of novel cyclodextrin transfection complexes by intestinal epithelial cells. Int J Pharm. 2011;413(1–2):174–183.
   PubMedGoogle Scholar
• Yu M, Yang Y, Zhu C, et al. Advances in the transepithelial transport of nanoparticles. Drug Discov Today. 2016;21(7):1155–1161.
   PubMed Web of Science ®Google Scholar
• Xu Z, Liu C, Wei J, et al. Effects of four types of hydroxyapatite nanoparticles with different nanocrystal morphologies and sizes on apoptosis in rat osteoblasts. J Appl Toxicol. 2012;32(6):429–435.
   PubMed Web of Science ®Google Scholar
• Zhang H, Hollis CP, Zhang Q, et al. Preparation and antitumor study of camptothecin nanocrystals. Int J Pharm. 2011;415(1–2):293–300.
   PubMedGoogle Scholar
• Modi SR, Dantuluri AKR, Puri V, et al. Impact of Crystal Habit on Biopharmaceutical Performance of Celecoxib. Cryst Growth Des. 2013;13(7):2824–2832.
   Web of Science ®Google Scholar
• Sun R, Guo Y, Yin N, et al. Preparation of sterile long-acting injectable medroxyprogesterone acetate microcrystals based on anti-solvent precipitation and crystal habit control. Expert Opin Drug Deliv. 2019;16(10):1744–7593.
   Web of Science ®Google Scholar
• Saaby L, Brodin B, Critical A. View on in vitro analysis of p-glycoprotein (p-gp) transport kinetics. J Pharm Sci. 2017;106(9):2257–2264.
   PubMed Web of Science ®Google Scholar
• Liu Y, Huang L, Liu F. Paclitaxel nanocrystals for overcoming multidrug resistance in cancer. Mol Pharm. 2010;7(3):863–869.
   PubMedGoogle Scholar
• Varma MVS, Panchagnula R. Enhanced oral paclitaxel absorption with vitamin E-TPGS: effect on solubility and permeability in vitro, in situ and in vivo. Eur J Pharm Sci. 2005;25(4–5):445–453.
   PubMed Web of Science ®Google Scholar
• Chen W, Miao YQ, Fan DJ, et al. Bioavailability study of berberine and the enhancing effects of tpgs on intestinal absorption in rats. AAPS PharmSciTech. 2011;12(2):705–711.
   PubMed Web of Science ®Google Scholar
• Collnot E-M, Baldes C, Schaefer UF, et al. Vitamin E TPGS P-glycoprotein inhibition mechanism: influence on conformational flexibility, intracellular ATP levels, and role of time and site of access. Mol Pharm. 2010;7(3):642–651.
   PubMed Web of Science ®Google Scholar
• Rege BD, Kao JPY, Polli JE. Effects of nonionic surfactants on membrane transporters in Caco-2 cell monolayers. Eur J Pharm Sci. 2002;16(4):237–246.
   PubMed Web of Science ®Google Scholar
• Ribeiro MENP, Moura CLD, Vieira MGS, et al. Solubilisation capacity of Brij surfactants. Int J Pharm. 2012;436(1–2):631–635.
   PubMed Web of Science ®Google Scholar
• Tang J, Wang Y, Wang D, et al. Key structure of Brij for overcoming multidrug resistance in cancer. Biomacromolecules. 2013;14(2):424–430.
   PubMed Web of Science ®Google Scholar
• Hua Y, Qing HY, Ip FCF, et al. Intestinal transport of bis(12)-hupyridone in Caco-2 cells and its improved permeability by the surfactant Brij-35. Biopharm Drug Dispos. 2011;32(3):140–150.
   PubMed Web of Science ®Google Scholar
• Collnot EM, Baldes C, Wempe MF, et al. Influence of vitamin E TPGS poly(ethylene glycol) chain length on apical efflux transporters in Caco-2 cell monolayers. J Control Release. 2006;111(1–2):35–40.
   PubMed Web of Science ®Google Scholar
• Popov A, Enlow E, Bourassa J, et al. Nanocrystals, compositions, and methods that aid particle transport in mucus. United States patent US 20130323179 A1; 2015 Jun 5.
   Google Scholar
• Li X, Chen D, Le C, et al. Novel mucus-penetrating liposomes as a potential oral drug delivery system: preparation, in vitro characterization, and enhanced cellular uptake. Int J Nanomedicine. 2011;6:3151–3162.
   PubMed Web of Science ®Google Scholar
• Zhang X, Dong W, Cheng H, et al. Modulating intestinal mucus barrier for nanoparticles penetration by surfactants. Asian J Pharm Sci. 2019;14(5):543–551.
   PubMed Web of Science ®Google Scholar
• Wang X, Du M, Han H, et al. Boundary lubrication by associative mucin. Langmuir. 2015;31(16):4733–4740.
   PubMed Web of Science ®Google Scholar
• Chi-Yuan C, Jia-Yu W, Ravinath K, et al. Nature of interactions between PEO-PPO-PEO triblock copolymers and lipid membranes: (II) role of hydration dynamics revealed by dynamic nuclear polarization. Biomacromolecules. 2018;13(9):2624–2633.
   Google Scholar
• Ueda K, Iwai T, Sunazuka Y, et al. Effect of molecular weight of hypromellose on mucin diffusion and oral absorption behavior of fenofibrate nanocrystal. Int J Pharm. 2019;564:39–47.
   PubMed Web of Science ®Google Scholar
• Goodwin DJ, Sepassi S, King SM, et al. Characterization of polymer adsorption onto drug nanoparticles using depletion measurements and small-angle neutron scattering. Mol Pharm. 2013;10(11):4146–4158.
   PubMedGoogle Scholar
• Yoncheva K, Guembe L, Campanero MA, et al. Evaluation of bioadhesive potential and intestinal transport of pegylated poly(anhydride) nanoparticles. Int J Pharm. 2007;334(1–2):156–165.
   PubMedGoogle Scholar
• Pridgen EM, Alexis F, Farokhzad OC. Polymeric nanoparticle drug delivery technologies for oral delivery applications. Expert Opin Drug Deliv. 2015;12(9):1459–1473.
   PubMed Web of Science ®Google Scholar
• Costabile G, Provenzano R, Azzalin A, et al. PEGylated mucus-penetrating nanocrystals for lung delivery of a new FtsZ inhibitor against Burkholderia cenocepacia infection. Nanomedicine. 2019;23:102113.
   PubMed Web of Science ®Google Scholar
• Justin T, Huckaby B, Samuel K, et al. PEGylation for enhancing nanoparticle diffusion in mucus. Adv Drug Deliv Rev. 2018;124:125–139.
   PubMed Web of Science ®Google Scholar
• Sakai-Kato K, Yoshida K, Izutsu K. Effect of surface charge on the size-dependent cellular internalization of liposomes. Chem Phys Lipids. 2019;224:104726.
   PubMed Web of Science ®Google Scholar
• Choi JS, Park JS. Effects of paclitaxel nanocrystals surface charge on cell internalization. Eur J Pharm Sci. 2016;93:90–96.
   PubMed Web of Science ®Google Scholar
• Kurakula M, El-Helw AM, Sobahi TR, et al. Chitosan based atorvastatin nanocrystals: effect of cationic charge on particle size, formulation stability, and in-vivo efficacy. Int J Nanomedicine. 2015;10:321–334.
   PubMed Web of Science ®Google Scholar
• Alama T, Kusamori K, Katsumi H, et al. Absorption-enhancing effects of gemini surfactant on the intestinal absorption of poorly absorbed hydrophilic drugs including peptide and protein drugs in rats. Int J Pharm. 2016;499(1–2):58–66.
   PubMedGoogle Scholar
• Maisel K, Ensign L, Reddy M, et al. Effect of surface chemistry on nanoparticle interaction with gastrointestinal mucus and distribution in the gastrointestinal tract following oral and rectal administration in the mouse. J Control Release. 2015;197:48–57.
   PubMed Web of Science ®Google Scholar
• Yu Z, Fan W, Wang L, et al. Effect of Surface Charges on Oral Absorption of Intact Solid Lipid Nanoparticles. Mol Pharm. 2019;16(12):5013–5024.
   PubMedGoogle Scholar
• Peng K, Shi Y, Labarbiera A. et al. Mucoadhesive ionic liquid gel patches for oral delivery. AACS Biomater Sci Eng. 2020; 2373–9878.
   Google Scholar
• Shan W, Zhu X, Liu M, et al. Overcoming the diffusion barrier of mucus and absorption barrier of epithelium by self-assembled nanoparticles for oral delivery of insulin. Acs Nano. 2015;9(3):2345–2356.
   PubMed Web of Science ®Google Scholar
• Rabinow BE. Nanosuspensions in drug delivery. Nat Rev Drug Discov. 2004;3(9):785–796.
   PubMed Web of Science ®Google Scholar
• Li Z, Qiu L, Chen Q, et al. pH-sensitive nanoparticles of poly(l-histidine)–poly(lactide-co-glycolide)–tocopheryl polyethylene glycol succinate for anti-tumor drug delivery. Acta Biomater. 2015;11:137–150.
   PubMed Web of Science ®Google Scholar
• Liu Y, Wang Y, Zhao J. Design, optimization and in vitro-in vivo evaluation of smart nanocaged carrier delivery of multifunctional PEG-chitosan stabilized silybin nanocrystals. Int J Biol Macromol. 2019;124:667–680.
   PubMed Web of Science ®Google Scholar
• Xia D, Tao J, He Y, et al., Enhanced transport of nanocage stabilized pure nanodrug across intestinal epithelial barrier mimicking Listeria monocytogenes. Biomaterials. 37(37C): 320–332. 2015.
   PubMedGoogle Scholar
• Roger E, Lagarce F, Garcion E, et al. Lipid nanocarriers improve paclitaxel transport throughout human intestinal epithelial cells by using vesicle-mediated transcytosis. J Control Release. 2009;140(2):174–181.
   PubMed Web of Science ®Google Scholar
• Li X, Wang X, Sha L, et al. Thermo-sensitive lipid bilayer coated mesoporous carbon nanoparticles for synergistic thermo-chemotherapy of tumor. ACS Appl Mater Interfaces. 2018;10(23):19386–19397.
   PubMed Web of Science ®Google Scholar
• Dumontel B, Canta M, Engelke H, et al. Enhanced biostability and cellular uptake of zinc oxide nanocrystals shielded with a phospholipid bilayer. J Mater Chem B. 2017;5(44):8799–8813.
   PubMed Web of Science ®Google Scholar
• Li T, Nowell CJ, Cipolla D, et al. Direct comparison of standard transmission electron microscopy and cryogenic-TEM in imaging nanocrystals inside liposomes. Mol Pharm. 2019;16(4):1775–1781.
   PubMedGoogle Scholar
• Li T, Mudie ST, Cipolla D, et al. Solid state characterization of ciprofloxacin liposome nanocrystals. Mol Pharm. 2019;16(1):184–194.
   PubMedGoogle Scholar
• Torchilin VP. Recent advances with liposomes as pharmaceutical carriers. Nat Rev Drug Discov. 2005;4(2):145–160.
   PubMed Web of Science ®Google Scholar
• Aller SG, Yu J, Ward A, et al. Structure of P-glycoprotein reveals a molecular basis for poly-specific drug binding. Science. 2009;323(5922):1718–1722.
   PubMed Web of Science ®Google Scholar
• Allam A, Hamdallah S, Abdallah O. Chitosan-coated diacerein nanosuspensions as a platform for enhancing bioavailability and lowering side effects: preparation, characterization, and ex vivo/in vivo evaluation. Int J Nanomedicine. 2017;12:4733–4745.
   PubMed Web of Science ®Google Scholar
• Pm V, Em P, M R, et al. Microfluidic platform for combinatorial synthesis and optimization of targeted nanoparticles for cancer therapy. Acs Nano. 2011;7(12):10671–10680.
   Web of Science ®Google Scholar
• Ahmed A, Sherif H, Ossama A, et al. Chitosan-coated diacerein nanosuspensions as a platform for enhancing bioavailability and lowering side effects: preparation, characterization, and ex vivo/in vivo evaluation. Int J Nanomedicine. 2017;12:4733–4745.
   PubMed Web of Science ®Google Scholar
• Lu Y, Low P. Folate-mediated delivery of macromolecular anticancer therapeutic agents. Adv Drug Deliv Rev. 2002;54(5):675–693.
   PubMed Web of Science ®Google Scholar
• Li L, Liu Y, Wang J, et al. Preparation, in vitro and in vivo evaluation of bexarotene nanocrystals with surface modification by folate-chitosan conjugates. Drug Deliv. 2016;23(1):79–87.
   PubMed Web of Science ®Google Scholar
• Pi-Ping L, Wei W, Hua Y, et al. Porous quaternized chitosan nanoparticles containing paclitaxel nanocrystals improved therapeutic efficacy in non-small-cell lung cancer after oral administration. Biomacromolecules. 2011;12(12):4230–4239.
   PubMed Web of Science ®Google Scholar
• Quan P, Shi K, Piao H, et al. A novel surface modified nitrendipine nanocrystals with enhancement of bioavailability and stability. Int J Pharm. 2012;430(1–2):366–371.
   PubMedGoogle Scholar
• Saha K, Rahimi M, Yazdani M, et al. Regulation of macrophage recognition through the interplay of nanoparticle surface functionality and protein corona. ACS Nano. 2016;10(4):4421.
   PubMed Web of Science ®Google Scholar
• Wang A, Yang T, Fan W, et al. Protein corona liposomes achieve efficient oral insulin delivery by overcoming mucus and epithelial barriers. Adv Healthc Mater. 2019;8(12):e1801123.
   PubMed Web of Science ®Google Scholar
• Zheng Y, Xing L, Chen L, et al. Tailored elasticity combined with biomimetic surface promotes nanoparticle transcytosis to overcome mucosal epithelial barrier. Biomaterials. 2020;262:120323.
   PubMed Web of Science ®Google Scholar
• Yin Y, Deng H, Wu K, et al. A multiaspect study on transcytosis mechanism of sorafenib nanogranules engineered by high-gravity antisolvent precipitation. J Control Release. 2020;323:600–612.
   PubMed Web of Science ®Google Scholar
• Wu L, Bai Y, Wang L, et al. Promoting apical-to-basolateral unidirectional transport of nanoformulations by manipulating the nutrient-absorption pathway. J Control Release. 2020;323:151–160.
   PubMed Web of Science ®Google Scholar
• Veiga N, Goldsmith M, Diesendruck Y, et al. Leukocyte-specific siRNA delivery revealing IRF8 as a potential anti-inflammatory target. J Control Release. 2019;313:33–41.
   PubMed Web of Science ®Google Scholar
• Banerjee A, Ibsen K, Brown T, et al. Ionic liquids for oral insulin delivery. Proc Natl Acad Sci U S A. 2018;115(28):7296–7301.
   PubMed Web of Science ®Google Scholar
• Al-Amin M, Bellato F, Mastrotto F, et al. Dexamethasone loaded liposomes by thin-film hydration and microfluidic procedures: formulation challenges. Int J Mol Sci. 2020;21(5):1611.
   PubMed Web of Science ®Google Scholar